[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].

Soldatov, M A; Marskaya, N A; Barsegova, K A; Androfagina, O V; Borisov, D N; Karpov, D Yu; Kishinevsky, M V; Kucheryavaya, M V; Tabakman, S V; Telyatnik, Yu A; Fadeeva, A S; Khan, D S; Chirkov, A N; Shamalov, N A

[Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R]. / Vnutrivennaya tromboliticheskaya terapiya ishemicheskogo insul'ta preparatom Reveliza v real'noi klinicheskoi praktike: promezhutochnye rezul'taty issledovaniya IVT-AIS-R.

Soldatov, M A; Marskaya, N A; Barsegova, K A; Androfagina, O V; Borisov, D N; Karpov, D Yu; Kishinevsky, M V; Kucheryavaya, M V; Tabakman, S V; Telyatnik, Yu A; Fadeeva, A S; Khan, D S; Chirkov, A N; Shamalov, N A.

Afiliação

Soldatov MA; Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency, Moscow, Russia.
Marskaya NA; Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency, Moscow, Russia.
Barsegova KA; Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency, Moscow, Russia.
Androfagina OV; Seredavin Samara Regional Clinical Hospital, Samara, Russia.
Borisov DN; Kirov Regional Clinical Hospital, Kirov, Russia.
Karpov DY; City Hospital No. 5, Barnaul, Russia.
Kishinevsky MV; Berzon Krasnoyarsk Interdistrict Clinical Hospital No. 20, Krasnoyarsk, Russia.
Kucheryavaya MV; Sergiev Posad District Hospital, Sergiev Posad, Russia.
Tabakman SV; Pirogov City Hospital No. 1, Sevastopol, Russia.
Telyatnik YA; Research Institute - Ochapovsky Regional Clinical Hospital No. 1, Krasnodar, Russia.
Fadeeva AS; Vladivostok Clinical Hospital No. 1, Vladivostok, Russia.
Khan DS; Primorskaya Regional Clinical Hospital No. 1, Vladivostok, Russia.
Chirkov AN; Orenburg Regional Clinical Hospital, Orenburg, Russia.
Shamalov NA; Institute of Cerebrovascular Pathology and Stroke, Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency, Moscow, Russia.

Zh Nevrol Psikhiatr Im S S Korsakova ; 121(3. Vyp. 2): 33-37, 2021.

Article em Ru | MEDLINE | ID: mdl-33908230

Assuntos

Isquemia Encefálica; Diabetes Mellitus Tipo 2; AVC Isquêmico; Acidente Vascular Cerebral; Idoso; Isquemia Encefálica/complicações; Isquemia Encefálica/tratamento farmacológico; Feminino; Fibrinolíticos/uso terapêutico; Humanos; Masculino; Estudos Prospectivos; Acidente Vascular Cerebral/tratamento farmacológico; Terapia Trombolítica; Resultado do Tratamento

Palavras-chave

Revelisa; alteplase; biosimilar; ischemic stroke; reperfusion therapy; systemic thrombolysis; thrombolytic therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isquemia Encefálica / Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 / AVC Isquêmico Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: Ru Revista: Zh Nevrol Psikhiatr Im S S Korsakova Assunto da revista: NEUROLOGIA / PSIQUIATRIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google